BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8380687)

  • 1. [Cisplatinum compounds].
    Ota K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nedaplatin].
    Ota K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):379-87. PubMed ID: 8712835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organo-platinum complexes as antitumor agents (review).
    Hill JM; Speer RJ
    Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of carboplatin].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1949-58. PubMed ID: 2203318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase III study of DWA2114R for ovarian cancer].
    Kato T; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Yamabe T; Yajima A; Fujimoto S; Hashimoto M; Nishiya I
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1285-93. PubMed ID: 1503482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of platinum analogues for the treatment of lung cancer].
    Nakai Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2157-62. PubMed ID: 1332625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental evaluation of cisplatin analogous in urogenital cancer].
    Machida T; Akasaka Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1386-92. PubMed ID: 2658827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of the clinical use of cycloplatin--a new derivative of cisplatin].
    Koralewski P; Pawlicki M
    Przegl Lek; 1992; 49(4):120-2. PubMed ID: 1332130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of CDDP analogs in gynecologic malignancies].
    Yakushiji M; Nishimura H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1393-8. PubMed ID: 2658828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.
    Kobayashi H; Takemura Y; Miyachi H; Ogawa T
    Invest New Drugs; 1991 Nov; 9(4):313-9. PubMed ID: 1804804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticancer drugs under clinical trials in Japan.
    Ogawa M; Ariyoshi Y
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):277-87. PubMed ID: 8040141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):387-91. PubMed ID: 2649007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
    Azzoli CG; Kris MG; Pfister DG
    J Natl Cancer Inst; 2007 Jun; 99(11):828-9. PubMed ID: 17551137
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
    Kobayashi K
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1747-56. PubMed ID: 8937484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.